Top

Global Chronic Obstructive Pulmonary Disease (COPD) Market 2014-2018

Category : Healthcare  | Published Date : Oct-2014 | Pages : 79
enquire GET DISCOUNT
About COPD
COPD is a broad term that covers various progressive lung diseases including emphysema, chronic bronchitis, refractory (non-reversible) asthma, and some forms of bronchiectasis. It is a serious condition that restricts airflow in the lungs and is characterized by increasing breathlessness. The exact etiology of COPD is not understood; however, most cases of COPD are caused due to genetic factors and by inhaling pollutants, including fumes and chemicals. The disease cannot be cured; it can be only be managed and treated. 
TechNavio's analysts forecast the Global COPD market to grow at a CAGR of 5.69 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global COPD market for the period 2014–2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs in the form of oral medications as well as inhalers for the treatment of COPD. The Global COPD market can be segmented into five: Medications, Oxygen Therapy, Surgery, Pulmonary Rehabilitation, and Lifestyle Changes. 
TechNavio's report, the Global COPD Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global COPD market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas 
• APAC
• EMEA        
Key Vendors
• Astra Zeneca
• Boehringer Ingelheim
• GlaxoSmithKline
• Novartis
• Pfizer 
Other Prominent Vendors
 
• Alere 
• Almirall 
• Astellas Pharma 
• Axis Shield
• Beckton Dckinson 
• Biosensors International 
• Dainippon Sumitomo Pharma 
• Medtronic 
• Merck
• Mylan
• Novartis
• Siemens Healthcare Diagnostics 
• Takeda Pharmaceutical
• Theravance 
Market Driver
• Elderly Population
• For a full, detailed list, view our report
Market Challenge
• High Cost of COPD Treatment
• For a full, detailed list, view our report
Market Trend
• Increase in Awareness of COPD
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01.Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1Market Overview
03.2Product Offerings
04.Market Research Methodology
04.1Market Research Process
04.2Research Methodology
05.Introduction
06.Market Landscape
06.1Market Overview
06.2Market Size and Forecast
07.Management of COPD
07.1Five Forces Analysis
08.Market Segmentation by Type of Treatment
09.Geographical Segmentation
09.1COPD Market in Americas
09.1.1Market Size and Forecast
09.2COPD Market in the EMEA Region
09.2.1Market Size and Forecast
09.3COPD Market in the APAC Region
09.3.1Market Size and Forecast
10.Buying Criteria
11.Rate of Incidence and Prevalence
11.1.1US
11.1.2Europe
11.1.3Asia
12.Pipeline Snapshot
13.Market Growth Drivers
14.Drivers and their Impact
15.Market Challenges
16.Impact of Drivers and Challenges
17.Market Trends
18.Trends and their Impact
19.Vendor Landscape
19.1Competitive Scenario
19.1.1Key News
19.1.2Mergers and Acquisitions
19.2Market Share Analysis 2013
19.3Other Prominent Vendors
20.Key Vendor Analysis
20.1AstraZeneca plc
20.1.1Key Facts
20.1.2Business Description
20.1.3Business Segmentation
20.1.4Business Strategy
20.1.5Revenue by Business Segmentation
20.1.6Revenue Comparison 2011-2013
20.1.7Sales Revenue by Geographical Segmentation
20.1.8Key Developments
20.1.9SWOT Analysis
20.2Boehringer Ingelheim
20.2.1Key Facts
20.2.2Business Overview
20.2.3Business Segmentation by Revenue 2013
20.2.4Business Segmentation by Revenue 2012 and 2013
20.2.5Geographical Segmentation by Revenue 2013
20.2.6Business Strategy
20.2.7Recent Developments
20.2.8SWOT Analysis
20.3GlaxoSmithKline plc
20.3.1Key Facts
20.3.2Business Overview
20.3.3Business Segmentation
20.3.4Business Segmentation by Revenue 2012 and 2013
20.3.5Sales by Geography
20.3.6Pipeline Products
20.3.7Business Strategy
20.3.8Key Information
20.3.9SWOT Analysis
20.4Pfizer Inc.
20.4.1Key Facts
20.4.2Business Description
20.4.3Business Segmentation
20.4.4Revenue by Business Segmentation
20.4.5Revenue Comparison 2012 and 2013
20.4.6Sales by Geography
20.4.7Business Strategy
20.4.8Key Developments
20.5SWOT Analysis
21.Other Reports in this Series
List of Exhibits
Exhibit 1:Market Research Methodology
Exhibit 2:Global COPD Market 2013-2018 (US$ billion)
Exhibit 3:Global COPD Market Segmentation by Type of Treatment
Exhibit 4:Global COPD Market Segmentation by Drug Class
Exhibit 5:Global COPD Market Segmentation by Drug Class 2013
Exhibit 6:Global COPD Market by Geographical Segmentation 2013
Exhibit 7:COPD Market in Americas 2013-2018 (US$ billion)
Exhibit 8:COPD Market in the EMEA Region
Exhibit 9:COPD Market in the APAC Region
Exhibit 10:Global COPD Market by Geographical Segmentation 2013-2018 (in percent)
Exhibit 11:Global COPD Market by Geographical Segmentation 2013-2018 (in revenue)
Exhibit 12:AstraZeneca plc: Business Segmentation
Exhibit 13:AstraZeneca plc: Revenue by Business Segmentation2013
Exhibit 14:AstraZeneca plc: Revenue by Business Segmentation 2011-2013 (US$ billion)
Exhibit 15:AstraZeneca plc: Sales Revenue by Geographical Segmentation 2013
Exhibit 16:Boehringer Ingelheim: Business Segmentation by Revenue 2013
Exhibit 17:Boehringer Ingelheim: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 18:Boehringer Ingelheim: Geographical Segmentation by Revenue 2013
Exhibit 19:GlaxoSmithKline plc: Business Segmentation 2013
Exhibit 20:GlaxoSmithKline plc: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 21:GlaxoSmithKline plc: Sales by Geography 2013
Exhibit 22:GlaxoSmithKline plc: Pipeline Products 2013
Exhibit 23:Pfizer Inc.: Business Segmentation
Exhibit 24:Pfizer Inc.: Revenue by Business Segmentation 2013
Exhibit 25:Pfizer Inc.: Revenue by Business Segmentation 2012 and 2013
Exhibit 26:Pfizer Inc.: Revenue by Geography 2013
...
Publisher Name : Technavio

SIMILAR MARKET STUDIES

Please Select Format
Single User: US $ 2500
Five User: US $ 2800
Site User: US $ 3500
Global User: US $ 10000

NEED MORE INFORMATION
Contact us
Call us +1-971-202-1575
--- or ---
help@bigmarketresearch.com
WHY BIG MARKET RESEARCH
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.
Top